Dr Edward Roddy

Dr Edward Roddy explains what gout is, and why attacks happen. He talks about why it is important to treat gout in the long-term as well as during attacks and describes different treatment options. He also explains current theories about why gout most commonly affects the big toe joint.

Dr Edward Roddy is a Clinical Senior Lecturer in Rheumatology at Keele University’s Arthritis Research UK Primary Care Centre and Consultant Rheumatologist at the Haywood Hospital in Stoke-on-Trent, UK. He graduated from the University of Nottingham in 1997 and subsequently undertook training in general medicine in Nottingham and Western Australia. On his return to the UK in 2001, he embarked upon specialist training in rheumatology. He undertook his doctoral thesis at the University of Nottingham, researching the epidemiology and treatment of gout in primary care. Since moving to Keele in 2007, he has maintained a strong clinical and academic interest in crystal arthropathies, leading epidemiological studies and clinical trials in gout. He has co-authored best practice recommendations for gout by the European League Against Rheumatism (EULAR) and the Arthritis and Musculoskeletal Alliance (ARMA).

A consultant rheumatologist explains why starting allopurinol can trigger attacks and why it can take up to two years for attacks to stop.

Gender Male

A consultant rheumatologist explains why uric acid levels can be normal during an attack.

Gender Male

A consultant rheumatologist explains how gout should be treated.

Gender Male

A consultant rheumatologist explains what long-term treatment for gout does, and why it is important.

Gender Male

A consultant rheumatologist explains what gout is.

Gender Male

A consultant rheumatologist talks about current theories explaining why gout is most common in the big toe.

Gender Male

A consultant rheumatologist explains how high levels of uric acid can cause gout.

Gender Male